Cargando…
Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells
Glioblastoma is the most aggressive form of primary brain cancer, with a median survival of 12–15 months. The P2X receptor 7 (P2X7R) is upregulated in glioblastoma and is associated with increased tumor cell proliferation. The cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) is als...
Autores principales: | Drill, Matthew, Powell, Kim L., Kan, Liyen Katrina, Jones, Nigel C., O’Brien, Terence J., Hamilton, John A., Monif, Mastura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481200/ https://www.ncbi.nlm.nih.gov/pubmed/32908225 http://dx.doi.org/10.1038/s41598-020-71887-x |
Ejemplares similares
-
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma
por: Kan, Liyen K., et al.
Publicado: (2023) -
The role of the purinergic P2X(7 )receptor in inflammation
por: Lister, Martin F, et al.
Publicado: (2007) -
Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
por: Schneider, Markus, et al.
Publicado: (2017) -
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011) -
Mitochondrial Localization and Function of the Purinergic Receptor P2X(7)
por: Kroemer, Guido, et al.
Publicado: (2021)